Review
Published on 17 Feb 2022
Targeting Microglia to Treat Degenerative Eye Diseases
in Multiple Sclerosis and Neuroimmunology
- 13,664 views
- 58 citations
Review
Published on 17 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 17 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 17 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 16 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 16 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 16 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 16 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 14 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 14 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 14 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 10 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 10 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 10 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 08 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 07 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 07 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 04 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 04 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 03 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 03 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 01 Feb 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 31 Jan 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 31 Jan 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 31 Jan 2022
in Multiple Sclerosis and Neuroimmunology